THOUSAND OAKS, Calif.,
July 23, 2020 /PRNewswire/
-- Amgen (NASDAQ:AMGN) today announced that it will report its
second quarter financial results on Tuesday,
July 28, 2020, after the close of the U.S. financial
markets. The announcement will be followed by a conference call
with the investment community at 2:00 p.m.
PT. Participating in the call from Amgen will be
Robert A. Bradway, chairman and
chief executive officer, and other members of Amgen's senior
Live audio of the conference call will be simultaneously
broadcast over the internet and will be available to members of the
news media, investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the event.
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
CONTACT: Amgen, Thousand
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631
Arvind Sood, 805-447-1060
View original content to download